Key Metrics of Subex Limited
Revenue₹256 Cr▼ 4.7% YoYFY 2025-26
EBITDA₹23.7 Cr▲ 176.0% YoY
Net profit₹5.86 Cr▲ 111.8% YoY
Net worth₹172 Cr▲ 4.1% YoY
Competitors10identified
About Subex Limited
Sectors
Company details
- Registered office
- Pritech Park - Sez, Block-09, 4th Floor, B Wing, Sy No. 51-64/4, Orr, Bellandur Vlg, Varthur Hobli Bengaluru, Bangalore, In-ka, 560103
- Listed
- NSE: SUBEXLTD · ₹16.89
Operational Areas of Subex Limited
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Entity details
CINL85110KA1994PLC016663
LEI code213800FG6KBKWBUEIJ07
State codeKA
PIN code560103
Current legal nameSUBEX LIMITED
Classification—
Listing statusListed (NSE: SUBEXLTD)
Registration no.016663
Company age—
PAN—
CountryIndia
CityBangalore
StateKarnataka
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—
Compliance
Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026
Industry classification
NIC code85110
Description of main activityHealth and social work
Description of business activityHealth and social work
SectorOther Industries · Discovered Companies
Premium
Financials, ratios and risk analysis
Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.
Sign in to continue See plans & pricingFiling compliance
AGM for FY 2025-2630 Sep 2026
Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026
Statutory due date · 3 days left
MGT-7 for FY 2025-2629 Nov 2026
Statutory due date · 33 days left
Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Credit ratings
CARE · 15 Jul 2014
—
Other
Change in last 12 monthsNo change
Change since first rating on record—since Feb 2009
Rating actions60 up · 0 down
Rating history
Rating actions
Borrowings & rated debt
Rated borrowing limits (latest)₹2,949 Cr
Peak rated limits₹14,418 CrMay 2010 · CARE
Limits raised2 times0 new facilities rated
Rated limits over time
Facility mix
Rated facilities
| Facility | Type | Previous | Current | Change | Rating | Action | Agency |
|---|---|---|---|---|---|---|---|
| Mobile: +91-9819009839 Mobile: +91-9819698985 E-mail: meenal.sikchi carerating.com E-mail: ankur.sachdeva careratings.com CREDIT ANALYSIS & RESEARCH LIMITED Cor | Other | ₹400 Cr | ₹22.0 Cr | −94.5% | — | Other | CARE |
| Tel: +91-22-6754 | Fax: +91-22-6754 | E-mail: care careratings.com Other Office: Kaledonia, Sahar Road, Near Andheri Railway Station, Andheri (E), Mumbai Tel: + | Other | ₹400 Cr | ₹69.0 Cr | −82.8% | — | Other | CARE |
| Satellite, Ahmedabad Madho Singh Road, Near Collectorate Circle | Other | ₹380 Cr | ₹15.0 Cr | −96.1% | — | Other | CARE |
| Cell: +91-98242 Bani Park, Jaipur 016. | Other | — | ₹302 Cr | — | — | Other | CARE |
| Tel: +91-79-4026 Cell: +91 – E-mail: mehul.pandya careratings.com Tel: +91-141-402 E-mail: rahul.jain careratings.com BENGALURU Mr. Dinesh Sharma KOLKATA Unit N | Other | — | ₹560 Cr | — | — | Other | CARE |
| Cell: +91-99000 10A, Shakespeare Sarani, Kolkata 071. | Other | — | ₹700 Cr | — | — | Other | CARE |
| Tel: +91-80-4115 Cell: +91-98319 E-mail: dinesh.sharma careratings.com Tel: +91-33-E-mail: priti.agarwal careratings.com CHANDIGARH Mr. Sajan Goyal NEW DELHI 2n | Other | — | ₹160 Cr | — | — | Other | CARE |
| Cell: +91 Jhandewalan Extension, New Delhi 055. | Other | — | ₹110 Cr | — | — | Other | CARE |
| Tel: +91-172-5171 Cell: +91-98117 Email: sajan.goyal careratings.com Tel: +91-11-4533 E-mail: swati.agrawal careratings.com CHENNAI Mr. V Pradeep Kumar PUNE Uni | Other | — | ₹600 Cr | — | — | Other | CARE |
| Cell: +91 Plot No. Bhamburda, Senapati Bapat Road, Tel: +91-44-2849 Shivaji Nagar, Pune 015. | Other | — | ₹411 Cr | — | — | Other | CARE |
Credit assessment · Manufacturing
Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26
Indicative long-term—
Indicative short-term—
Score—
LiquidityAdequate
DirectionStable
CARE rating · Jul 2014—
Ratios, pillar scores and the indicative rating are part of Premium.
Rating status
| Default | No default on record |
| Issuer cooperation | Cooperating |
| Credit enhancement | None – standalone rating |
| Next action stable or better (model) | 35% |
| Information on file | 67% · missing: Capex / investment plans, Auditor details, Recent rating review (last 15 months) |
Indicative assessment from public data using the published methodology factors; not a credit rating.
Borrowing & funding lifecycle
Can it borrow more?Further bank funding difficult
Next rating action stable or better: 41% (At risk of downgrade) · ML model on 4072 rating histories, AUC 0.666
Rated limits₹2,949 Cr
Not yet allocated—
Extra debt within 2.5× EBITDA—
Interest coverage—
Limit utilisation—
Open bank charges0 · —
- Credit outlook model: 41% chance the next rating action is stable or better
Rated limits by facility
Timeline
Lender names, bank charges and audited borrowings are part of Premium.
Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.
Registered office and contact
Registered officePRITECH PARK - SEZ, BLOCK-09, 4TH FLOOR, B WING, SY NO. 51-64/4, ORR, BELLANDUR VLG, VARTHUR HOBLI BENGALURU, BANGALORE, IN-KA, 560103
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Subex Limited
Competitors10identified
Locations3most in India
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
 Dr. Reddy's Laboratories |
Part of Dr. Reddy's Laboratories. | drreddys.com | 1984 | India |
 Aurobindo Pharma |
Part of Aurobindo Pharma. | aurobindo.com | 1986 | Hyderabad, India |
 Cipla |
Part of Cipla. | cipla.com | 1935 | Mumbai, India |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lupin.com | 1968 | India | |
 Glenmark Pharmaceuticals |
Part of Glenmark Pharmaceuticals. | glenmarkpharma.com | 1977 | Mumbai, India |
| Part of Biocon. | biocon.com | 1978 | Bangalore, India | |
 ALKEM LABORATORIES LIMITED |
Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | alkemlabs.com | 1973 | Mumbai, Maharashtra, India |
 Torrent Pharmaceuticals |
Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | torrentpharma.com | 1959 | Ahmedabad, India |
| ASTER DM QUALITY CARE LIMITED | Discovered Companies · Other Industries | — | — | Hyderabad, Telangana, India |
 Thomas Cook India |
Part of Thomas Cook Group. | thomascook.in | 1978 | Mumbai, India |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.